Esperion Therapeutics | ESPR - Le Chiffre D'Affaires De Vente





Ventes Changement Date
AbbVie USD 15B 1.62B 2026-03
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Amarin USD 49.22M 451K 2025-12
Amgen USD 8.62B 1.28B 2026-03
Biogen USD 2.25B 30M 2026-03
BioMarin Pharmaceutical USD 766M 109M 2026-03
Cipla INR 65.41B 9.77B 2026-03
CSL USD 8.33B 4.79B 2025-12
Cytokinetics USD 19.35M 1.59M 2026-03
Daiichi Sankyo JPY 587B 28.89B 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Geron USD 51.84M 3.82M 2026-03
Grifols EUR 2B 306.7M 2026-03
Halozyme Therapeutics USD 377M 74.76M 2026-03
Heron Therapeutics USD 40.59M 2.38M 2025-12
Ionis Pharmaceuticals USD 246M 43M 2026-03
Merck USD 16.29B 110M 2026-03
Minerva Neurosciences USD 0 0 2024-09
Moderna USD 389M 289M 2026-03
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Pfizer USD 14.5B 3.08B 2026-03
PTC Therapeutics USD 273M 108.3M 2026-03
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Sanofi EUR 11.24B 60M 2026-03
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
United Therapeutics USD 781.5M 8.7M 2026-03
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12